A detailed history of Hsbc Holdings PLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 153,831 shares of PRCT stock, worth $12.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
153,831
Holding current value
$12.5 Million
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $8.66 Million - $13.1 Million
153,831 New
153,831 $12.3 Million
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $1.08 Million - $1.36 Million
26,763 Added 25.04%
133,633 $6.6 Million
Q4 2023

Feb 12, 2024

BUY
$24.89 - $43.41 $633,201 - $1.1 Million
25,440 Added 31.24%
106,870 $4.48 Million
Q3 2023

Nov 13, 2023

BUY
$30.02 - $38.81 $242,081 - $312,963
8,064 Added 10.99%
81,430 $2.67 Million
Q2 2023

Aug 11, 2023

BUY
$26.7 - $37.02 $1.96 Million - $2.72 Million
73,366 New
73,366 $2.59 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.62B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.